£132.74

Opioid Use and Misuse in the Medicare System - Nova Science

Price data last checked 9 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 82 days • 82 data points (No recent data available)

Historical
Generating forecast...
£132.74 £129.44 £130.16 £130.88 £131.60 £132.32 £133.04 28 January 2026 17 February 2026 09 March 2026 29 March 2026 19 April 2026

Price Distribution

Price distribution over 82 days • 2 price levels

Days at Price
Current Price
36 days 46 days · current 0 12 23 35 46 £130 £133 Days at Price

Price Analysis

Most common price: £133 (46 days, 56.1%)

Price range: £130 - £133

Price levels: 2 different prices over 82 days

Description

As the Medicare program provides healthcare coverage to over 58 million beneficiaries, it plays a significant role in the management of opioid prescriptions. In the aging population over 65, Medicare accounts for a large share of total opioid use. Data from 2016 shows that one out of every three beneficiaries was prescribed an opioid through Medicare Part D. While many beneficiaries with serious pain-related conditions receive proper prescriptions, there is growing evidence regarding opioid misuse within the Medicare system. This book examines the complexities of this issue, providing a detailed look at the current landscape of prescription trends and the risks involved for the elderly population. Readers will find an analysis of proposed programs designed to improve screening processes. By focusing on these methods, the text explores how early detection of potential opioid use can be achieved to improve patient safety and healthcare outcomes within the Medicare framework.

Key Features

Analyzes the impact of Medicare Part D on opioid prescription rates for the over 65 population.

Explores the balance between necessary pain management and the rising evidence of opioid misuse.

Examines proposed programs aimed at increasing screening effectiveness for beneficiaries.

Provides insight into early detection methods for potential opioid use within the healthcare system.

Offers a detailed look at how Medicare serves its 58 million beneficiaries regarding drug prescriptions.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
04 February 2020
Listed Since
11 October 2019

Barcode

No barcode data available

Similar Products You Might Like

The Opioid Crisis: Use and Misuse of Prescription, Illicit and Synthetic Opioids (Alcohol and Drug Abuse)
92% match

The Opioid Crisis: Use and Misuse of Prescription, Illicit and Synthetic Opioids (Alcohol and Drug Abuse)

£106.49 09 Mar 2026
PRESCRIPTION DRUGS (Substance Abuse Assassment Interventions and Treatment)
92% match

PRESCRIPTION DRUGS (Substance Abuse Assassment Interventions and Treatment)

Brand: Nova Science Pub Inc

£66.51 27 Feb 2026
Medicare Part B: Premiums & High-Expenditure Drugs (Health Care Issues, Costs and Access)
91% match

Medicare Part B: Premiums & High-Expenditure Drugs (Health Care Issues, Costs and Access)

£72.23 13 Apr 2026
Prescription Drug Abuse: Reduction Efforts & Federal Role (Alcohol and Drug Abuse)
91% match

Prescription Drug Abuse: Reduction Efforts & Federal Role (Alcohol and Drug Abuse)

£69.24 09 Mar 2026
Medicare: Value-Based Care, Pharmacy Benefit Managers, Trust Fund Reports and Fee-For-Service (Health Care in Transition)
91% match

Medicare: Value-Based Care, Pharmacy Benefit Managers, Trust Fund Reports and Fee-For-Service (Health Care in Transition)

£152.99 09 Feb 2026
Medicare s Prescription Drug Program: Competition Issues & Cost Trends
91% match

Medicare s Prescription Drug Program: Competition Issues & Cost Trends

£110.38 06 Jan 2026
U.S. Drug Supply, Investigational Drugs and E-Prescriptions
91% match

U.S. Drug Supply, Investigational Drugs and E-Prescriptions

£152.99 12 Jan 2026
Prescription Drug Diversion and Pain: History, Policy, and Treatment
91% match

Prescription Drug Diversion and Pain: History, Policy, and Treatment

Oxford University Press

£51.00 21 Feb 2026
Improving Medicare (Health Care Issues, Costs and Access)
91% match

Improving Medicare (Health Care Issues, Costs and Access)

£172.03 11 Jan 2026
Opioids: Pharmacology, Abuse, and Addiction
91% match

Opioids: Pharmacology, Abuse, and Addiction

Springer

£78.56 25 Feb 2026
Opioids: Pharmacology, Abuse, and Addiction
91% match

Opioids: Pharmacology, Abuse, and Addiction

Springer

£77.82 26 Jan 2026
Medicaid & Treatment for People with Substance Abuse Problems (Health Care Issues, Costs and Access)
91% match

Medicaid & Treatment for People with Substance Abuse Problems (Health Care Issues, Costs and Access)

£149.40 11 Jan 2026
Opioids in Medicine: A Comprehensive Review on the Mode of Action and the Use of Analgesics in Different Clinical Pain States
91% match

Opioids in Medicine: A Comprehensive Review on the Mode of Action and the Use of Analgesics in Different Clinical Pain States

Springer

£109.40 30 Jan 2026
Opioids in Medicine: A Comprehensive Review on the Mode of Action and the Use of Analgesics in Different Clinical Pain States
91% match

Opioids in Medicine: A Comprehensive Review on the Mode of Action and the Use of Analgesics in Different Clinical Pain States

Springer

£169.54 27 Jan 2026
Prescription Drugs: Development, Pricing and Abuse (Health Care in Transition)
90% match

Prescription Drugs: Development, Pricing and Abuse (Health Care in Transition)

£109.49 02 Mar 2026
Treating Opioid Addiction (Current Clinical Psychiatry)
90% match

Treating Opioid Addiction (Current Clinical Psychiatry)

Humana

£75.22 06 Feb 2026
Medicare: Current Issues and Background
90% match

Medicare: Current Issues and Background

£26.69 08 Mar 2026
Pain Management & Opioid Therapy Guidelines from the Veterans Administration & Department of Defense (Military and Veteran Issues, Public Health in the 21st Century)
90% match

Pain Management & Opioid Therapy Guidelines from the Veterans Administration & Department of Defense (Military and Veteran Issues, Public Health in the 21st Century)

£163.15 28 Jan 2026
Medicare, Health Care Delivery & Payment Reform Recommendations (Health Care Issues, Costs & Access Series) (Health Care Issues, Costs and Access)
90% match

Medicare, Health Care Delivery & Payment Reform Recommendations (Health Care Issues, Costs & Access Series) (Health Care Issues, Costs and Access)

£87.16 12 Jan 2026
Prescription Drugs: Global Perspectives, Long-Term Effects & Abuse Prevention (Pharmacology - Research, Safety Testing and Regulation)
90% match

Prescription Drugs: Global Perspectives, Long-Term Effects & Abuse Prevention (Pharmacology - Research, Safety Testing and Regulation)

£76.49 01 Mar 2026
FRAUD DETECTION DETERRENCE (Health Care Issues, Costs and Access)
90% match

FRAUD DETECTION DETERRENCE (Health Care Issues, Costs and Access)

Nova Science Publishers Inc

£92.30 11 Jan 2026
Analgesics: New Research (Pharmacology - Research, Safety Testing and Regulation)
90% match

Analgesics: New Research (Pharmacology - Research, Safety Testing and Regulation)

£86.83 11 Mar 2026
BUPRENORPHINE PHARMACOLOGY CLINICAL: Pharmacology, Clinical Uses & Potential Side Effects (Pharmacology-research, Safety Testing and Regulation)
90% match

BUPRENORPHINE PHARMACOLOGY CLINICAL: Pharmacology, Clinical Uses & Potential Side Effects (Pharmacology-research, Safety Testing and Regulation)

£109.76 25 Jan 2026
Medicare Part D Prescription Drug Benefit: Elements, Provisions & Integrity Issues
90% match

Medicare Part D Prescription Drug Benefit: Elements, Provisions & Integrity Issues

Nova Science Publishers Inc

£68.33 07 Mar 2026